Last reviewed · How we verify

paracetamol /droperidol — Competitive Intelligence Brief

paracetamol /droperidol (paracetamol /droperidol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Analgesic/Antipyretic combined with Antipsychotic/Antiemetic. Area: Pain Management, Acute Care.

phase 3 Analgesic/Antipyretic combined with Antipsychotic/Antiemetic Cyclooxygenase (COX) enzymes; Dopamine D2 receptor Pain Management, Acute Care Small molecule Live · refreshed every 30 min

Target snapshot

paracetamol /droperidol (paracetamol /droperidol) — University Hospital, Limoges. Paracetamol reduces pain and fever through inhibition of prostaglandin synthesis, while droperidol is an antipsychotic and antiemetic that blocks dopamine receptors.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
paracetamol /droperidol TARGET paracetamol /droperidol University Hospital, Limoges phase 3 Analgesic/Antipyretic combined with Antipsychotic/Antiemetic Cyclooxygenase (COX) enzymes; Dopamine D2 receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Analgesic/Antipyretic combined with Antipsychotic/Antiemetic class)

  1. University Hospital, Limoges · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). paracetamol /droperidol — Competitive Intelligence Brief. https://druglandscape.com/ci/paracetamol-droperidol. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: